Periodontitis is a highly prevalent infectious disease associated genetically with coronary heart disease (CHD). The effects of proprotein convertase subtilisin/kexin type 9 (PCSK9), a critical regulator of CHD, on periodontitis have not been studied to date. Here, we found that PCSK9 expression was increased in periodontitis patients and Porphyromonas gingivalis (Pg)-infected mice. Loss of PCSK9 attenuated Pg-induced periodontal bone loss in mice. First, PCSK9 deficiency reduced the release of inflammation-associated cytokines, such as tumor necrosis factor alpha (TNF-α) and interleukin 1β, in vitro and in vivo. Second, its deficiency enhanced Pg and endotoxin clearance during Pg invasion in part by upregulating CD36 and low-density lipoprotein receptor (LDLR), respectively. However, after berberine treatment, periodontal bone regeneration in the PCSK9 knockout group was significantly lower than that in wild-type. This was because PCSK9 overexpression promoted osteogenic differentiation of periodontal ligament stem cells (PDLCs) prechallenged by TNF-α. Furthermore, PCSK9 could rescue PDLC osteogenesis by repressing the NF-κB signaling pathway by interacting with TRAF2. These results suggest that PCSK9 may be a potent drug target for treating periodontitis.
Periodontitis is a complex bacterial infection-induced inflammatory periodontal disease caused by imbalance between bacterial antigens and host immune reactions [1] . Periodontitis can be divided into 4 phases [2] : (1) bacterial invasion and biofilm formation; (2) soft tissues damaged by disordered inflammation response; (3) hard tissues damaged by excess osteoclast formation, attachment loss, and pocket formation; and (4) damage repaired by local stem cells following clinical treatment. A systematic review revealed that between 1990 and 2010, the age-standardized prevalence of severe periodontitis was static at 11.2% in the global adult population, making it the sixth most prevalent disease in the world [3] . Periodontitis is mainly caused by gram-negative bacteria, such as Porphyromonas gingivalis (Pg), and its lipopolysaccharide (LPS) continually stimulates periodontal tissue, causing host immune balance disorders [4] . This is not only the main factor leading to tooth loss but can also exacerbate metabolic disease, such as coronary heart disease (CHD) and diabetes [5] . The meta-analysis indicates that periodontitis is associated with prevalence and incidence of CHD [6] . Additionally, periodontal treatment can improve endothelial function in the long term [7] . Recent studies indicate a genetic relationship between CHD and periodontitis [8] .
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a secretory protein and can degrade low-density lipoprotein receptor (LDLR) directly through the endosome/lysosome pathways, thereby increasing serum low-density lipoprotein cholesterol (LDL-C) concentrations [9, 10] . Gain-of-function mutations in PCSK9 cause autosomal dominant hypercholesterolemia [11] , whereas loss-of-function mutations in PCSK9 decrease the serum LDL-C level, thereby reducing risk of CHD [12] . The first 2 PCSK9 inhibitors, namely, alirocumab and evolocumab, were recently approved by the US Food and Drug Administration to treat familial hypercholesterolemia and patients at risk of CHD [13] . Miyazawa et al demonstrated that patients with periodontitis display higher serum antibody titer to Pg and serum PCSK9 levels than do control subjects [14] . C57BL/6 mice also show increased serum PCSK9 and lipid levels compared with sham-infected mice when infected intraperitoneally with Pg [15] . Moreover, periodontal ligament stem cells (PDLCs) exist in periodontal tissues and participate mainly in periodontal tissue regeneration [16] . Inflammation decreases mature osteoblast function and impairs production and maturation of bone matrix ability of bone marrow mesenchymal stem cells (BMSCs) by activating the NF-κB pathway [17] . Our previous study revealed that inhibition of NF-κB activity can promote osteogenic differentiation of BMSCs [18] . These studies indicate that CHD-related PCSK9 may be involved in periodontitis development, which has never been reported before.
METHODS

Mice, Bacteria, and Other Reagents
PCSK9 −/− or wild-type (WT) mice (C57BL/6) were purchased from the Model Animal Research Center of Nanjing University (Nanjing, China). Animal care and study protocols were approved by the local Institutional Animal Ethics Committee.
Gingival Biopsies
Human gingiva, including sulcus/pocket epithelium and underlying connective tissue, were obtained from either healthy controls (n = 10; mean age, 30.1 ± 2.7 years; min-max, 22-46 years; 3 male/7 female) or patients with periodontitis (n = 9; mean age, 36.4 ± 3.4 years; min-max, 22-50 years; 4 male/5 female) with alveolar bone loss confirmed by radiography. Informed consent forms were signed and obtained from each subject. All protocols dealing with patients conformed to the ethical guidelines of the Helsinki Declaration and were approved by the Medical Ethics Committee of the Hospital of Stomatology, Wuhan University. Quantitative real-time polymerase chain reaction (qRT-PCR) was employed to determine the messenger RNA (mRNA) levels of PCSK9 and interleukin 1β (IL-1β) (primers listed in Supplementary Table 1) .
Periodontitis Model
Experimental periodontitis was induced in mice by oral inoculation with Pg following previous protocols with minor modifications [19] . In brief, WT and PCSK9 knockout mice were initially given kanamycin (1 mg/mL) in drinking water for 7 days to reduce the native flora. Mice were orally inoculated thrice within 48 hours at the first and second weeks (a total of 6 inoculations) with 2 × 10 9 colony-forming units (CFU) Pg suspended in 2% carboxy-methylcellulose vehicle after an antibiotic-free period for 3 days. Sham control mice from each group (WT and knockout) received vehicle alone.
Stereomicroscopy and Micro-Computed Tomography Study
The left maxilla from at least 6 mice in each group was dissected and immersed in 4% paraformaldehyde at room temperature. Detailed protocols and analysis of data are described in the Supplementary Experimental Procedures.
Histological Evaluation
Following the micro-computed tomography (CT) scan, samples were decalcified using 10% ethylenediaminetetraacetic acid (EDTA). Serial sections of 5 µm thickness were cut and mounted on polylysine-coated slides. Hematoxylin and eosin staining was performed separately on consecutive tissue sections. Images were captured using a microscope. The distance from the cemento-enamel junction (CEJ) to the alveolar bone crest (ABC) between the maxillary first and second molars was measured using ImageJ software (National Institutes of Health). Tartrate-resistant acid phosphatase (TRAP) activity was detected using a leukocyte-specific acid phosphatase kit (SigmaAldrich, Shanghai, China) according to previous protocols [20, 21] . The number of multinucleated osteoclast cells (nuclei ≥3) per square millimeter in an area including the alveolar bone between the maxillary first and third molars (4 × 2 mm) was counted. For each mouse, 4 histological sections were measured by 2 independent observers blinded to the groups of mice. The averages of these measurements were analyzed.
Real-time qPCR
The right alveolar bone including the maxillary first and third molars was collected (n = 5). Total RNA was extracted using Trizol (Invitrogen, Wuhan, China). First-strand complementary DNA was transcribed from 1 μg of RNA using PrimeScript RT Master Mix (Takara, Dalian, China) according to the manufacturer's protocol. Detailed protocols and analysis of data are described in the Supplementary Experimental Procedures.
Isolation and Stimulation of Mouse BMSCs
The isolation and culture of mouse BMSCs (mBMSCs) from the tibias and femurs of 8-week-old mice was performed as described previously [18] . Upon reaching 70%-80% confluence, adherent cells were stimulated by Pg-LPS (500 ng/mL, InvivoGen, Shanghai, China) challenge for 16 hours. The culture medium was used to detect expression of PCSK9, IL-1β, and TNF-α protein by enzyme-linked immunosorbent assay (ELISA). Then, cells were lysed and mRNA of PCSK9, IL-1β, TNF-α, and receptor activator of nuclear factor kappa-B ligand (RANKL) were measured by qRT-PCR. Immunofluorescence staining was used to detect PCSK9 and LDLR of mBMSCs.
ELISA Detection of PCSK9, IL-1β, and TNF-α Levels
PCSK9, IL-1β, TNF-α, and RANKL levels in the culture medium and mice serum were measured using ELISA kits (Boston, Wuhan, China) following the manufacturer's protocol. Unstimulated cells were used as negative controls.
Immunofluorescence Staining
Detailed protocols and analysis of data are described under the Supplementary Experimental Procedures.
Phagocytosis of bone marrow macrophages (BMMs)
Nonadherent cells were collected, plated in 6-well plates with glass slides at a concentration of 3 × 10 5 cells/cm 2 , and incubated in the presence of macrophage colony-stimulating factor (M-CSF) (30 ng/mL) for 2 days. Cells were stimulated with heat-killed fluorescein isothiocyanate (FITC)-labeled Pg (multiplicity of infection of 1:50) for 6 hours. The F-actin and nuclei were visualized by staining the cells with 4' ,6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich, Shanghai, China) and tetramethylrhodaminephalloidin (Qcbio S&T, Shanghai, China), respectively. They were observed under a fluorescent microscope (DP71, Olympus, China) and photographed. Nine visual fields were selected in each well. The total numbers of green fluorescent protein-positive bacteria in each well were counted using ImageJ.
Pg numbers in mouse maxilla were quantified as described previously [22] with minor modification. In brief, genomic DNA in the maxillary palatal and buccal gingiva and hard tissue (teeth and immediately surrounding bone) was extracted using the TIANamp Genomic DNA kit (Tiangen, Beijing, China). TaqMan qRT-PCR was employed to detect the levels of Pg (ISPg1 gene) and total bacteria (16S ribosomal RNA [rRNA]) in periodontal tissue. Real-time PCR was performed using the ABI 7500 Fast System. Primers and TaqMan probes were the same as described previously [23] .
LPS Clearance by bone marrow macrophages (BMMs)
LPS clearance activity of bone marrow macrophages (BMMs) was detected as described previously [24] with minor modification. The BMMs were plated in 6-well plates at a concentration of 1 × 10 5 cells/cm 2 . LDLR small interfering RNA (siRNA; Genepharma, Shanghai, China) was transiently transfected. Cells were treated with Alexa Fluor 488-conjugated LPS (Invitrogen, L-23351, Shanghai, Chian) or with standard nonfluorescent LPS (Sigma-Aldrich, L2880, Shanghai, China) as control after 48 hours. Twenty-four hours later, cells were resuspended in phosphate-buffered saline at a concentration of 1 × 10 6 cells/mL, and then analyzed by flow cytometry (Beckman Coulter Gallios Flow Cytometer, Wuhan, China). The output of interest was mean fluorescence intensity (MFI) from the instrument's FL1 laser (excitation wavelength = 488 nm). Data analysis was performed using FlowJo 7.6.1 software.
siRNA Transfection
Target sequences for siRNA against murine LDLR, CD36, and scrambled siRNA control (nontargeting siRNA pool) were purchased from Genepharma (Shanghai, China). The BMMs were cultured in 6-well plates and transiently transfected with LDLR and CD36 siRNA or control siRNA at a concentration of 50 nM using Lipofectamine 2000 (Invitrogen, Wuhan, China), following the manufacturer's protocol. These assays were performed as described previously [18] with minor modification. Experimental procedures are described in the Supplementary Experimental Procedures.
Western Blot Analysis
Cells were infected with different lentiviral vectors. After 48 hours, cell culture medium was collected and cells were lysed in radio immunoprecipitation assay (RIPA) buffer (Beyotime, China) and centrifuged, and the supernatant was collected to examine protein expression. Detailed protocols and analysis of data are described in the Supplementary Experimental Procedures.
Statistical Analyses
All experiments were performed at least 3 times. Data were analyzed with SPSS version 16.0 and GraphPad Prism version 5.0 software. Statistical significance of differences among groups was examined using 1-way analysis of variance (ANOVA) and homogeneity of variance tests. Post hoc Tukey test was conducted if ANOVA indicated a significant difference. The final results were expressed as mean ± standard deviation. Values were considered significantly different if P < .05.
RESULTS
PCSK9 Plays an Important Role in Periodontitis Patients and Mice
First, we sought to examine whether PCSK9 was expressed in human gingival tissues and whether its expression was affected by inflammatory status. As shown in Figure 1A and 1B, mRNA levels of PCSK9 were significantly increased in the diseased group compared to healthy controls as well as IL-1β.
Immunohistochemistry staining also confirmed that Pg infection increased PCSK9 expression in mouse periodontal tissues ( Figure 1C1 -D3), whereas levels of LDLR, a PCSK9 target protein, was decreased ( Figure 1E and 1F).
PCSK9 Deficiency Attenuated Mouse Periodontitis by Inhibiting Inflammatory Reaction In Vivo
Next, the oral gavage model was employed to investigate roles of PCSK9 in the development of Pg-induced periodontitis. Both stereoscopic microscopy and micro-CT scanning study revealed that Pg-infected mice showed more bone loss than sham-treated controls ( In a recent in vivo study, mice injected with lentivirus-mediated PCSK9 short hairpin RNA had less aortic atherosclerotic plaque formation and decreased expression of vascular inflammation regulators, such as TNF-α, IL-1β, and MCP-1, compared with the control group [25] . These findings demonstrated that PCSK9 knockout alleviated Pg-induced periodontitis by downregulating inflammatory and osteoclastogenic molecules in local tissues.
Loss of PCSK9 Repressed Inflammatory Reaction In Vitro
Immunocytochemistry showed that Pg-LPS (500 ng/mL) challenge for 16 
Loss of PCSK9 Increased Pg or Pg-LPS Clearance In Vivo and In Vitro
Phagocyte from the innate immune system is a first line of defense and is essential for the host response to infection via recognition of phagocytic capacities [26] . The impaired phagocytosis ability of macrophage leads to severe periodontitis progression [27] . On this basis, we asked whether attenuation of periodontitis in PCSK9 knockout mice was mediated via regulation of the innate immune system. Pg infection significantly increased Pg and total bacteria number in periodontal tissue compared with Comparison of proprotein convertase subtilisin/kexin type 9 (PCSK9) and interleukin 1β (IL-1β) levels within human gingival tissues (A and B). Porphyromonas gingivalis (Pg) infection increases PCSK9 expression and decreases low-density lipoprotein receptor (LDLR) expression in mouse periodontal tissues (C1-F). A and B, messenger RNA (mRNA) levels of PCSK9 and IL-1β were increased in patients with periodontitis (n = 9) compared with healthy controls (n = 10). C1-D3, Immunofluorescence staining for PCSK9 expression in periodontal tissue from mice 6 weeks postinfection with Pg or vehicle control. C1-C3, Wild-type (WT) mice. D1-D3, Pg-challenged WT mice. C1 and D1, DAPI (4',6-diamidino-2-phenylindole) staining. C2 and D2, Fluorescein isothiocyanate (FITC)-conjugated secondary antibody staining. C3 and D3, merge. E and F, Immunohistochemistry staining for LDLR expression in periodontal tissue from mice 6 weeks postinfection with Pg or vehicle control, E, WT mice. F, Pg-challenged WT mice. Scale bar = 50 μm. a vs healthy controls, P < 0.05. Abbreviations: al, alveolar bone; de, dentine; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; gi, gingiva; PBS, phosphate-buffered saline.. their sham-infected controls ( Figure 5A ). PCSK9 knockout mice showed obviously lower Pg number and total bacteria numbers at 8 weeks compared with those in the Pg-infected WT mouse group after being infected by Pg ( Figure 5A ). Darveau and Hajishengallis [28] proposed that, as a "keystone" species, Pg changes both the amount and composition of oral microbiota, which induces dysbiosis, leading to periodontal bone loss. Berberine, as an antimicrobial agent, significantly decreased Pg numbers and total periodontal bacteria numbers up to the sham-infected group levels ( Figure 5A ). pCD36 is abundantly expressed in phagocytic cells and mediates diverse biological processes and acts as a modulator of the early innate immune response [29] . In our study, loss of PCSK9 significantly increased CD36 expression in mBMMs, which was efficiently abolished by CD36 siRNA (Figure 5B and 5C ). Then, phagocytic and clearance ability of primary BMMs against Pg was detected in vitro. PCSK9 knockout enhanced the ability of BMMs to phagocytose FITC-labeled Pg (Figure 5D-G4) . The upregulated phagocytic ability of FITC-labeled Pg could be partially attenuated by addition of CD36 siRNA ( Figure 5D and 5G1-G4).
Much of the physiopathology of periodontal diseases can be explained by the local biological activity of LPS [30] . Therefore, the ability of BMMs to clear LPS (LPS-Alexa 488) was examined by flow cytometry ( Figure 5H ). PCSK9 knockout led to 2-fold increase in MFI, while the addition of LDLR siRNA partially attenuated it ( Figure 5I ). These results demonstrated that loss of PCSK9 helped maintain a normal symbiotic microbiota and to eliminate pathogen lipid.
Berberine, a Broad-Spectrum Antimicrobial Agent, Ameliorates Mice Periodontitis
Berberine, an isoquinoline plant alkaloid, has been used to treat hypercholesterolemia [31] . In the present study, berberine treatment ameliorated Pg-induced periodontitis in WT and PCSK9 knockout mice as confirmed by micro-CT ( Figure 6A-E) . However, new alveolar bone regeneration was decreased in PCSK9 knockout mice compared with wild-type mice following berberine treatment ( Figure 6F-H) . Results of ELISA revealed that Pg infection induced significant elevation of serum PCSK9, TNF-α, and IL-1β levels, whereas PCSK9 knockout and berberine treatment decreased their levels ( Figure 6I-K) . The berberine treatment group exhibited significantly low mRNA expression of the inflammatory mediators IL-1β, TNF-α, and RANKL compared with the control group ( Figure 6L ). These data indicated that berberine can be a promising therapeutic agent against periodontitis.
PCSK9 Rescues Osteogenic Differentiation of PDLCs by Repressing NF-κB
Signaling via Interactions With TNF Receptor-Associated Factor 2
To further examine the impact of PCSK9 on alveolar bone regeneration under inflammatory microenvironments, a lentiviral vector system was employed to efficiently overexpress PCSK9 in primary PDLCs. Expression of PCSK9 in PDLCs and its function on LDLR was examined by Western blot and immunofluorescence, respectively ( Figure 7A-C3 ). PCSK9 overexpression did not alter the proliferation ability of PDLCs, whereas the proliferation and osteogenic differentiation ability of PDLCs was significantly decreased by pretreatment with 20 ng/mL TNF-α ( Figure 7D ). The decreased osteogenic ability was partially rescued by PCSK9 overexpression, which was demonstrated by ALP activity assay, ALP staining, and von Kossa staining as well as quantification of RUNX2 and OCN mRNA expression by qRT-PCR ( Figure 7E-O) . These findings revealed that PCSK9 overexpression was beneficial to periodontal tissue regeneration under inflammatory microenviroments in vitro.
Tumor necrosis factor receptor-associated factor 2 (TRAF2) is an intracellular signal-transducing protein that binds to cellular inhibitors of apoptosis 1 (c-IAP1) and cIAP2 (cIAP1/2) and recruits them to the TNFR1 and TNFR2 receptors following TNF stimulation to activate the NF-κB signaling pathway [32] . Immunofluorescent double staining showed that both PCSK9 and TRAF2 protein were present and co-localized in the cytoplasm of PDLCs (Figure 7P1-P4) . Western blot showed that PCSK9 was significantly upregulated at days 4 and 12 during the natural osteogenic differentiation process, whereas TRAF2 was significantly downregulated at day 12 ( Figure 7Q and 7R). Co-immunoprecipitation experiments revealed that PCSK9 directly interacted with TRAF2 protein ( Figure 7S ). Furthermore, dual luciferase reporter assay was employed to study the effect of PCSK9 overexpression on the TNF-α pathway. The result demonstrated that PCSK9 overexpression can attenuate TNF-α-induced NF-κB signaling pathway activity ( Figure 7T ), which might be beneficial to periodontal tissue repair in the presence of inflammation.
DISCUSSION
Periodontitis is a complex infectious and inflammatory disease caused by imbalance between microbial invasion and host immune response. In our study, PCSK9 knockout generally decreased periodontal bone tissue loss and attenuated Pg-induced periodontitis in vivo.
Several animal models, such as the ligature, oral gavage, LPS injection, and mandibular critical size defect models, are available to study the pathological process of periodontal disease [33] . The oral gavage model has often been employed to investigate the development of Pg-induced periodontitis and its relationship with systemic diseases, such as atherosclerosis [34] . For this reason, this model was used in our study. Expression of PCSK9 was significantly upregulated following Pg-challenge, accompanied by increased inflammatory mediators IL-1β and TNF-α, which are key inflammatory cytokines in response to Pg infection and mediate osteoclast differentiation [35, 36] . Inflammatory and osteoclastogenesis-related factors are derived from several types of cells in periodontal tissues, such as lymphocytes, osteoblast, PDLCs, and many other cell types [37] . Bone resorption-related factor RANKL was highly expressed on the surface of mBMSCs and mainly secreted by BMSCs-derived osteoblasts in response to bone-resorbing factors, such as LPS [38] . Therefore, primary mBMSCs consisting of various cells were isolated to clarify whether the observed decrease in osteoclastic formation was partially caused by reduction in the release of inflammatory factors. PCSK9 knockout mBMSCs displayed decreased IL-1β, TNF-α, and RANKL release in response to Pg challenge based on qRT-PCR and ELISA assays. These results are consistent with those of a recent study in which hPCSK9 overexpression significantly increased the expression of proinflammatory cytokines (IL-1β and TNF-α) in LPS-stimulated murine peritoneal macrophages, and decreased anti-inflammatory factors (IL-10 and ARG-1) in vitro [39] .
Hajishengallis et al demonstrated that the numbers and community organization of the commensal bacteria were essential for Pg-induced bone loss [40] . PCSK9 deficiency enhanced clearance of Pg in periodontal tissue verified by TaqMan qRT-PCR. The total number of bacteria also decreased upon PCSK9 knockout. Increase in Pg phagocytosis by BMMs upon PCSK9 knockout was CD36-dependent in vitro because CD36 siRNA reduced the number of pathogenic microbes, which contain lipid moieties in their cell walls that act as major ligands for innate immune receptors in triggering inflammatory response, such as LPS in gram-negative bacteria [41] . Decreased PCSK9 function results in increased pathogen lipid clearance through the LDLR to reduce inflammatory response and improve septic shock outcome [24] . In the present study, PCSK9-deficient BMMs showed increased LPS clearance ability, which was only partially attenuated upon addition of LDLR siRNA. Thus, other LPS clearance-related receptors regulated by PCSK9, such as low-density lipoprotein receptor-related protein 1 (LRP-1), may also be involved in this process [42] . Berberine inhibits osteoclast formation and survival of BMMs through suppression of NF-κB and Akt activation, so both pathways in the osteoclast lineage are highly sensitive to berberine treatment [43] . In the present study, treatment of periodontitis mice with berberine reduced alveolar bone resorption, serum PCSK9, and inflammatory factors. On one hand, berberine can directly inhibit osteoclast formation, which was demonstrated in our in vitro experiments. On the other hand, berberine can decrease periodontal degradation by inhibiting matrix metalloproteinases in periodontitis induced by bacterial plaques [44] .
Once damaged, the periodontium exhibits a capacity for repair via recruitment of local stem cells that can differentiate into periodontal ligament cells, mineral-forming cementoblasts, or bone-forming osteoblasts [45] . PDLCs have the greatest potential for regeneration of periodontium tissues. In our study, PDLCs showed increased PCSK9 expression accompanied by decreased TRAF2 expression when induced into osteogenic differentiation. TRAF2 plays important roles in mediating activation of the NF-κB signaling pathway [46] . Increased NF-κB activity has been shown to decrease mature osteoblast function and impair production and maturation of bone matrix [17] . Co-immunoprecipitation experiments have revealed that PCSK9 interacts with TRAF2. Xu et al also found that the c-IAP1/TRAF2 complex can bind PCSK9 [47] . Moreover, PCSK9 overexpression decreased TNF-α-induced activation of the NF-κB signaling pathway in PDLCs in dual luciferase reporter assays. Together, these results indicate that PCSK9 may enhance the osteogenic capacity of PDLC cells via TRAF2 in an inflammatory microenvironment, which may in turn promote periodontal healing. In summary (see Supplementary Scheme 1), our results revealed that loss of PCSK9 was beneficial to Pg-induced mouse periodontitis by enhancing Pg and Pg-LPS clearance through CD36 and LDLR, but detrimental to periodontal tissue regeneration after treatment. Furthermore, PCSK9 deficiency reduced Pg-induced inflammation-associated cytokine release in mice periodontal tissue. The best strategy for clinical treatment of periodontitis may utilize the different target effects of PCSK9 on periodontal balance.
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